1,628
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

The global prevalence of premature ovarian insufficiency: a systematic review and meta-analysis

, , , , &
Pages 95-102 | Received 27 Jul 2022, Accepted 23 Nov 2022, Published online: 15 Dec 2022

References

  • Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol. 2008;68(4):499–509.
  • Webber L, Davies M, Anderson R, et al. ESHRE guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31(5):926–937.
  • Allshouse AA, Semple AL, Santoro NF. Evidence for prolonged and unique amenorrhea-related symptoms in women with premature ovarian failure/primary ovarian insufficiency. Menopause. 2015;22(2):166–174.
  • Gallagher JC. Effect of early menopause on bone mineral density and fractures. Menopause. 2007;14(3 Pt 2):567–571.
  • Roeters VLJ, Heida KY, Bots ML, et al. Cardiovascular disease risk in women with premature ovarian insufficiency:a systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23(2):178–186.
  • Torrealday S, Kodaman P, Pal L. Premature ovarian insufficiency – an update on recent advances in understanding and management. F1000Res. 2017;6):2069.
  • Nelson SM, Anderson RA. Prediction of premature ovarian insufficiency: foolish fallacy or feasible foresight? Climacteric. 2021;24(5):438–443.
  • Luborsky JL, Meyer P, Sowers MF, et al. Premature menopause in a multi-ethnic population study of the menopause transition. Hum Reprod. 2003;18(1):199–206.
  • Mondul AM, Rodriguez C, Jacobs EJ, et al. Age at natural menopause and cause-specific mortality. Am J Epidemiol. 2005;162(11):1089–1097.
  • Sun L, Tan L, Yang F, et al. Meta-analysis suggests that smoking is associated with an increased risk of early natural menopause. Menopause. 2012;19(2):126–132.
  • Gold EB, Crawford SL, Avis NE, et al. Factors related to age at natural menopause: longitudinal analyses from SWAN. Am J Epidemiol. 2013;178(1):70–83.
  • Dorjgochoo T, Kallianpur A, Gao YT, et al. Dietary and lifestyle predictors of age at natural menopause and reproductive span in the Shanghai Women’s health study. Menopause. 2008;15(5):924–933.
  • Aydin ZD. Determinants of age at natural menopause in the Isparta menopause and health study: premenopausal body mass index gain rate and episodic weight loss. Menopause. 2010;17(3):494–505.
  • Morris DH, Jones ME, Schoemaker MJ, et al. Body mass index, exercise, and other lifestyle factors in relation to age at natural menopause: analyses from the breakthrough generations study. Am J Epidemiol. 2012;175(10):998–1005.
  • van Noord PA, Dubas JS, Dorland M, et al. Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors. Fertil Steril. 1997;68(1):95–102.
  • Whalley LJ, Fox HC, Starr JM, et al. Age at natural menopause and cognition. Maturitas. 2004;49(2):148–156.
  • Kuh D, Butterworth S, Kok H, et al. Childhood cognitive ability and age at menopause: evidence from two cohort studies. Menopause. 2005;12(4):475–482.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
  • Rockville B. Agency for healthcare research and quality. ISNA Bulletin. 2007;25(suppl 1):S1.
  • Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
  • Lim YM, Jeong K, Lee SR, et al. Association between premature ovarian insufficiency, early menopause, socioeconomic status in a nationally representative sample from Korea. Maturitas. 2019;121:22–27.
  • Netterlid A, Mörse H, Giwercman A, et al. Premature ovarian failure after childhood cancer and risk of metabolic syndrome: a cross-sectional analysis. Eur J Endocrinol. 2021;185(1):67–75.
  • Ceccarelli F, Orefice V, Perrone G, et al. Premature ovarian failure in patients affected by systemic lupus erythematosus: a cross-sectional study. Clin Exp Rheumatol. 2020;38(3):450–454.
  • Parazzini F, De Aloysio D, Di Donato P, et al. Premature Ovarian failure: frequency and risk factors among women attending a network of menopause clinics in Italy. Int J Obst Gynaecol. 2003;110:59–63.
  • Chemaitilly W, Li Z, Krasin MJ, et al. Premature Ovarian insufficiency in childhood cancer survivors: a report from the St. Jude lifetime cohort. J Clin Endocrinol Metab. 2017;102(7):2242–2250.
  • Jutiviboonsuk A, Salang L, Eamudomkarn N, et al. Prevalence and clinical associations with premature ovarian insufficiency, early menopause, and low ovarian reserve in systemic sclerosis. Clin Rheumatol. 2021;40(6):2267–2275.
  • Andany N, Kaida A, de Pokomandy A, et al. Prevalence and correlates of early-onset menopause among women living with HIV in Canada. Menopause. 2020;27(1):66–75.
  • Akawatcharangura P, Taechakraichana N, Osiri M. Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand. Lupus. 2016;25(4):436–444.
  • Rostami DM, Bidhendi-Yarandi R, Mohammad K, et al. Prevalence of premature ovarian insufficiency and its determinants in Iranian populations: Tehran lipid and glucose study. BMC Womens Health. 2021;21(1):79.
  • Haller-Kikkatalo K, Uibo R, Kurg A, et al. The prevalence and phenotypic characteristics of spontaneous premature ovarian failure: a general population registry-based study. Hum Reprod. 2015;30(5):1229–1238.
  • Lagergren K, Hammar M, Nedstrand E, et al. The prevalence of primary ovarian insufficiency in Sweden; a national register study. BMC Womens Health. 2018;18(1):175.
  • Vogt EC, Breivik L, Røyrvik EC, et al. Primary Ovarian insufficiency in women with Addison’s disease. J Clin Endocrinol Metab. 2021;106(7):e2656-63–e2663.
  • Mayorga J, Alpízar-Rodríguez D, Prieto-Padilla J, et al. Prevalence of premature ovarian failure in patients with systemic lupus erythematosus. Lupus. 2016;25(7):675–683.
  • Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67(4):604–606.
  • Golezar S, Ramezani TF, Khazaei S, et al. The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis. Climacteric. 2019;22(4):403–411.
  • Giri R, Vincent AJ. Prevalence and risk factors of premature Ovarian insufficiency/early Menopause. Semin Reprod Med. 2020;38(4–5):237–246.
  • Stevenson JC, Collins P, Hamoda H, et al. Cardiometabolic health in premature ovarian insufficiency. Climacteric. 2021;24(5):474–480.
  • Tao XY, Zuo AZ, Wang JQ, et al. Effect of primary ovarian insufficiency and early natural menopause on mortality: a meta-analysis. Climacteric. 2016;19(1):27–36.
  • Tsiligiannis S, Panay N, Stevenson JC. Premature Ovarian insufficiency and Long-Term health consequences. Curr Vasc Pharmacol. 2019;17(6):604–609.
  • Eshre P, Guideline DG. Management of women with premature ovarian insufficiency. Guideline Eur Soc Hum Reprod Embryol. 2015;56–57.
  • Rudnicka E, Kruszewska J, Klicka K, et al. Premature ovarian insufficiency – aetiopathology, epidemiology, and diagnostic evaluation. Prz Menopauzalny. 2018;17(3):105–108.
  • Kirshenbaum M, Orvieto R. Premature ovarian insufficiency (POI) and autoimmunity-an update appraisal. J Assist Reprod Genet. 2019;36(11):2207–2215.
  • Grossmann B, Saur S, Rall K, et al. Prevalence of autoimmune disease in women with premature ovarian failure. Eur J Contracept Reprod Health Care. 2020;25(1):72–75.
  • Dittmar M, Kahaly GJ. Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up. J Clin Endocrinol Metab. 2003;88(7):2983–2992.
  • Marca AL, Brozzetti A, Sighinolfi G, et al. Primary ovarian insufficiency: autoimmune causes. Curr Opin Obstet Gyn. 2010;22(4):277–282.
  • Beitl K, Rosta K, Poetsch N, et al. Autoimmunological serum parameters and bone mass density in premature ovarian insufficiency: a retrospective cohort study. Arch Gynecol Obstet. 2021;303(4):1109–1115.
  • Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update. 2005;11(4):391–410.
  • Kokcu A. Premature ovarian failure from current perspective. Gynecol Endocrinol. 2010;26(8):555–562.
  • Larsen EC, Müller J, Schmiegelow K, et al. Reduced ovarian function in long-term survivors of radiation-and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab. 2003;88(11):5307–5314.
  • Nelson LM, Covington SN, Rebar RW. An update: spontaneous premature ovarian failure is not an early menopause. Fertil Steril. 2005;83(5):1327–1332.
  • Luoto R, Kaprio J, Uutela A. Age at natural menopause and sociodemographic status in Finland. Am J Epidemiol. 1994;139(1):64–76.
  • Gold EB, Bromberger J, Crawford S, et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol. 2001;153(9):865–874.
  • Lynch JW, Smith GD, Kaplan GA, et al. Income inequality and mortality: importance to health of individual income, psychosocial environment, or material conditions. BMJ. 2000;320(7243):1200–1204.
  • Winkleby MA, Jatulis DE, Frank E, et al. Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health. 1992;82(6):816–820.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.